AI-generated summary
The authors report a randomized, blinded controlled trial of 30 hospitalized patients with sepsis, comparing vascular photobiomodulation applied to the radial artery against a control group. From day three, the treated group showed reductions in several blood and metabolic markers, which the authors associate with the intervention. The sample was small and the abstract does not describe certainty of these findings beyond the reported statistics.
- Participants
- 30
- Who or what was studied
- Hospitalized patients with sepsis
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a small sample of 30 participants and does not report long-term outcomes or clinical endpoints such as mortality.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Total energy
- 180 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Placebo-controlled, Control group, Biomarker, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.